Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated and combined statements of cash flows

v3.22.1
Consolidated and combined statements of cash flows - MXN ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Jan. 03, 2021
Dec. 31, 2019
Operating activities:      
Net income for the year $ 1,800,884 $ 338,361 $ 472,142
Adjustments for:      
Income tax expense 824,454 542,768 232,692
Depreciation and amortization 82,122 43,688 38,394
Accounting effects for changing reporting period (22,466)    
Interest expense 75,818 80,253 85,429
Interest income (25,872) (10,930) (7,028)
(Gain) loss on disposal of non-current assets (478) 9,216  
Share-based payment expense   32,910  
Others (12,974)    
Changes in fair value of warrants   851,520  
Unrealized gain (loss) in valuation of derivative financial instruments (330,315) 287,985 15,680
Total adjustments to reconcile profit (loss) 2,391,173 2,175,771 837,309
(Increase) decrease in:      
Trade accounts receivable (19,720) (510,719) (48,311)
Trade accounts receivable from related parties (24) 610 (610)
Inventory (64,312) (928,472) (43,348)
Prepaid expenses and other assets 31,184 (95,532) (40,263)
Accounts payable to suppliers and accrued expenses (81,882) 1,604,591 101,857
Provisions (35,843) 104,319 7,703
Value-added tax payable (26,703) (3,596) 12,675
Statutory employee profit sharing 47,951 2,348 2,290
Employee benefits 1,722 (743) 351
Income taxes paid (777,949) (526,321) (224,207)
Net cash provided by operating activities 1,465,597 1,822,256 605,446
Investing activities:      
Control obtained over subsidiaries 50    
Payments of fixed and intangible assets (401,736) (617,686) (182,625)
Proceeds from disposal of fixed assets 12,521 18,270  
Interest received 25,872 10,930 7,028
Restricted cash 42,915 (42,915)  
Net cash used in investing activities (320,378) (631,401) (175,597)
Financing activities:      
Proceeds from borrowings 1,520,000 1,712,207 104,500
Repayment of borrowings (646,716) (1,757,112) (83,041)
Repayment of derivative financial instruments (18,172)    
Bond emission costs (18,931)    
Interest paid on borrowings (49,123) (121,297) (82,654)
Restricted cash     22,940
Lease payments (6,899) (8,825) (12,325)
Cash received for issuance of shares   250,295  
Dividends paid (1,400,000) (830,000) (342,955)
Net cash used in financing activities (619,841) (754,732) (393,535)
Increase in cash and cash equivalents 525,378 436,123 36,314
Cash and cash equivalents at the beginning of year 649,820 213,697 177,383
Cash and cash equivalents at the end of year $ 1,175,198 $ 649,820 $ 213,697